RxDoctor Payments Data

Courtney Warner, PA

Physician Assistant · Wexford, PANPI 1932743416

Payments from drug & device makers

$2,146in general payments, 2019–2025

Across 156 payments — averaging $13.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Heartflow, Inc.$638
  • Novartis$541
  • Amgen$427
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$168
  • Impulse Dynamics (USA) Inc.$82
  • Johnson & Johnson$66
  • plus $223 from 9 others

What the payments were for

  • Food & beverage$2,146100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,146 in reported general payments places this provider in the 85th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$3,925
Medicare patients
46
Services billed
54

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban31$31,280
JardianceEmpagliflozin25$23,552
XareltoRivaroxaban19$13,213
Diltiazem 24hr Er (Cd)Diltiazem Hcl25$569
Bumetanide11$493
Metoprolol Succinate50$353
Valsartan15$205
ClopidogrelClopidogrel Bisulfate31$130
Atorvastatin Calcium33$124
Metoprolol Tartrate19$109
Losartan Potassium11$71
Carvedilol13$40
Spironolactone11$39
Furosemide16$17
Hydrochlorothiazide14$13

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$17$23,55225 claims
Johnson & JohnsonXarelto$66$13,21319 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in Wexford

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →